Contact Us
Drug Search Results
More Filters [+]

Sodium polystyrene sulfonate

Alternative Names: sodium polystyrene sulfonate, sps, kalexate, kionex, kayexalate
Latest Update: 2024-12-12
Latest Update Note: News Article

Product Description

Sodium polystyrene sulfonate is used to treat high levels of potassium in the blood, also called hyperkalemia. (Sourced from: https://www.mayoclinic.org/drugs-supplements/sodium-polystyrene-sulfonate-oral-route-route-not-applicable/description/drg-20073487)

Mechanisms of Action: Potassium Reducer

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intramuscular

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Australia | Austria | Bangladesh | Belgium | Brazil | Chile | Colombia | Dominican Republic | Egypt | France | Germany | Hong Kong | India | Ireland | Italy | Malaysia | Morocco | New Zealand | Pakistan | Taiwan | Tunisia | United Kingdom | United States | Venezuela | Vietnam

Approved Indications: Hyperkalemia

Known Adverse Events: Colitis | Colitis, Ischemic | Fecal Impaction | Anorexia | Constipation | Diarrhea | Bezoars

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sodium polystyrene sulfonate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

12/12/2024

News Article

 Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic ADI Platform, Advancing Toward First-in-Human Clinical Trials

12/10/2024

News Article

 Seattle Expands Youth Mental Health Supports with Launch of Talkspace Virtual Therapy

12/09/2024

News Article

 2717 Partners Sends Letter to Logility Board Calling for a Review of Strategic Alternatives

12/06/2024

News Article

 Orbit International's Power Group Reports Bookings in Excess of $1,000,000 for the Month of November 2024

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions